Inhalation Sciences ships PreciseInhale order worth 1.5 MSEK to Asia, delivering 209% yearly sales increase
(Stockholm Nov 1, 2019) Inhalation Sciences (ISAB) has successfully shipped a PreciseInhale to Singapore, in a second order from an existing customer worth 1.5 MSEK. CEO Manoush Masarrat: “This order brings our sales figures up to and including October 2019 to 6.8 MSEK, an increase of 209% compared to the same period in 2018.”
'For the second month in a row, we have successfully shipped a PreciseInhale instrument to a large customer,” says Masarrat. “This order is worth 1.5 MSEK. It brings our sales figures up to and including October 2019 to 6.8 MSEK, that is an increase of 209% compared to the same period in 2018.”
Masarrat is particularly pleased that the order was from an existing customer who wants a system in their Asian market, having achieved successful results with it in their European facilities.
"It sends a very strong message about the strategic value of our technology when existing customers invest in another instrument," says Masarrat “and it confirms our ability to successfully manufacture and ship complex systems in large orders processed over a longer period. It’s also proof that our work building customer relations really bore fruit with the whole organization, including my predecessor, pulling hard for the business. The future looks bright for Inhalation Sciences and we’re looking forward to a strong end to 2019. '
For more information about Inhalation Sciences, please contact:
Manoush Masarrat, VD
E-mail: Manoush.masarrat@inhalation.se
Mobile: +46 (0)73 628 9153
About Inhalations Sciences Sweden AB (publ)
Inhalation Sciences Sweden AB (publ) develops and commercializes world-leading instruments for research in inhalation. The company’s patented lab instrument, PreciseInhale®, enables researchers to characterize, with high precision, how aerosols and small particles impact our lungs, and so our health, when we inhale.
The information above was provided through the agency of the contact person above, for publication on November 1, 2019.